iCAD, Inc. Reports 2013 Fourth Quarter And Full Year Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news